Supplier
Swedish Orphan Biovitrum
Milano · ITA
Track this recordFree account — get alerted when a contract here runs out.
Awards
4
Total awarded
€4.5m
4 / 4 with a value
Buyers
1
Sectors
1
Reg. 05288990962
Contracts this supplier holds that are running out
- 21 Nov 2026estimatedLONCASTUXIMAB TESIRINEPuntoZero S.c.ar.l.Swedish Orphan Biovitrum€1,937,489
- 21 Nov 2026estimatedANAKINRAPuntoZero S.c.ar.l.Swedish Orphan Biovitrum€515,554
- 8 May 2027estimatedEFMOROCTOCOG ALFAPuntoZero S.c.ar.l.Swedish Orphan Biovitrum€1,716,422
- 8 May 2027estimatedEFTRENONACOG ALFAPuntoZero S.c.ar.l.Swedish Orphan Biovitrum€364,320
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| EFTRENONACOG ALFA | PuntoZero S.c.ar.l. | Swedish Orphan Biovitrum | €364,320 | 7 May 2026 |
| EFMOROCTOCOG ALFA | PuntoZero S.c.ar.l. | Swedish Orphan Biovitrum | €1,716,422 | 7 May 2026 |
| ANAKINRA | PuntoZero S.c.ar.l. | Swedish Orphan Biovitrum | €515,554 | 20 Nov 2025 |
| LONCASTUXIMAB TESIRINE | PuntoZero S.c.ar.l. | Swedish Orphan Biovitrum | €1,937,489 | 20 Nov 2025 |